Medicines Formulary BNF Section 4 Central Nervous System
|
|
- Cassandra Lucinda Lawrence
- 5 years ago
- Views:
Transcription
1 Medicines BNF Section Hypnotics and anxiolytics Chloral Hydrate 500mg/5ml Solution Clomethiazole 192mg Capsules Lormetazepam Tablets Melatonin Capsules Nitrazepam Suspension Nitrazepam Tablets Temazepam Tablets Temazepam Sf Elixir Zolpidem Tablets Zopiclone Tablets Chlordiazepoxide Capsules Diazepam Tablets Diazepam Suspension Diazepam Solution Diazepam Syrup Lorazepam Suspension Lorazepam Tablets Lorazepam Injection Not a hypnotic of choice not to be initiated in new patients. Only for patients already on therapy, or as a pre-med in paediatrics requiring scans Page 1 of 12
2 Medicines BNF Section Drugs used in psychoses and related disorders Amisulpride Tablets Amisulpride Solution Aripiprazole Oro Dispersible Tablets Aripiprazole Tablets Aripiprazole Solution Aripiprazole Injection Chlorpromazine Tablets Chlorpromazine Syrup Chlorpromazine Injection Clozapine Tablets Clozapine Suspension Haloperidol Tablets Haloperidol Sf Solution Haloperidol Capsules Haloperidol 5mg/1ml Injection Levomepromazine Tablets Levomepromazine Injection Olanzapine Injection Restricted for use in palliative care not dor the management of psychoses Restricted for use in palliative care not dor the management of psychoses Page 2 of 12
3 Medicines BNF Section 4 Olanzapine Orodispersible Tablets Olanzapine Tablets Quetiapine Tablets Quetiapine MR Tablets Risperidone Orodispersible Tablets Risperidone Tablets Risperidone Liquid Sulpiride Tablets Trifluoperazine Tablets Trifluoperazine Sf Solution Zuclopenthixol Tablets Zuclopenthixol Acetate Injection Flupentixol Decanoate Injection Fluphenazine Decanoate Injection Haloperidol Decanoate Injection Pipotiazine Injection Risperidone Injection Zuclopenthixol Decanoate Injection Lithium Carbonate M/R Tablets Page 3 of 12
4 Medicines BNF Section 4 Lithium Carbonate Tablets Lithium Citrate Syrup Valproic Acid As Semisodium Valproate Tabs Valproic Acid As Semisodium Valproate Tabs 4.3 Antidepressant drugs Amitriptyline Tablets Amitriptyline SF Solution Dosulepin Capsules Dosulepin Oral Solution Imipramine Tablets Lofepramine Tablets Lofepramine Suspension Nortriptyline Tablets Trazodone Capsules Trazodone Tablets Trazodone Sf Liquid Phenelzine Tablets Citalopram Tablets Citalopram Oral Drops Fluoxetine Capsules Fluoxetine Liquid Paroxetine Sf Liquid Page 4 of 12
5 Medicines BNF Section 4 Sertraline Tablets Duloxetine Capsules Mirtazapine Orodispersible Tablets Mirtazapine Tablets Venlafaxine M/R Capsules Venlafaxine Tablets 4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder Atomoxetine Capsules Caffeine Citrate Injection Methylphenidate Tablets Methylphenidate M/R Tablets Methylphenidate M/R Capsules Modafinil Tablets or initiated by CAMs or initiated by CAMs or initiated by CAMs Restricted to initiation by specialists 4.5 Drugs used in the treatment of obesity Orlistat 120mg Capsules Restricted to initiation by specialists following nationally agreed parameters 4.6 Drugs used in nausea and vertigo Aprepitant Capsules Betahistine Tablets Cinnarizine Tablets Cyclizine Tablets Cyclizine Injection Domperidone Tablets Restricted to specialist initiation only Page 5 of 12
6 Medicines BNF Section 4 Domperidone Suppositories Domperidone Suspension Droperidol Injection Fosaprepitant Injection Hyoscine Patch Hyoscine Hydrobromide Tablets Metoclopramide Tablets Metoclopramide Injection Metoclopramide Syrup Ondansetron Melt Tablets Ondansetron Tablets Ondansetron Injection Ondansetron Sf Syrup Prochlorperazine Injection Prochlorperazine Buccal Tablets Prochlorperazine Tablets Prochlorperazine Syrup Promethazine Teoclate Tablets Restricted to specialist initiation only 4.7 Analgesics Aspirin Suppositories R Aspirin Dispersible Tablets Ibuprofen Sf Suspension Paracetamol Infusion Paracetamol Suppositories Paracetamol Sf Suspension Paracetamol Suspension Page 6 of 12
7 Medicines BNF Section 4 Paracetamol Caplets Paracetamol Soluble Tablets Paracetamol Tablets Bupivacaine Infusion Buprenorphine Patches Buprenorphine S/L Tablets Buprenorphine Injection Codeine Phosphate Tablets Codeine Phosphate Syrup Codeine Phosphate Injection Diamorphine Injection Diamorphine Epidural Syringe Fentanyl Sublingual Tablets Fentanyl Patches Fentanyl Lozenges Fentanyl Injection Fentanyl Buccal Tablets Meptazinol Injection Meptazinol Tablets Methadone Injection Morphine Sulphate Tablets Morphine Sulphate M/R Capsules Morphine Sulphate Injection Morphine Sulphate Syringe Morphine Sulphate Solution Oxycodone Injection Restrict to use in opioid dependence, or palliative care only Page 7 of 12
8 Medicines BNF Section 4 Oxycodone Hydrochloride Solution Oxycodone Hydrochloride Sf Liquid Oxycodone Hydrochloride M/R Tablets Oxycodone Hydrochloride Capsules Pethidine Injection Pethidine Tablets Tramadol M/R Tablets Tramadol Injection Tramadol Capsules Tramadol 50mg Soluble Tablets Tapentadol Restricted MMC May 2014 Lidocaine 5% Patches Sumatriptan Tablets Sumatriptan Nasal Spray Sumatriptan Syringe (Plus Auto-Injector) Pizotifen. Tablets Pizotifen Elixir 4.8 Antiepileptic drugs Carbamazepine Chewable Tablets Carbamazepine Tablets Carbamazepine Sf Liquid Carbamazepine Suppositories Carbamazepine M/R Tablets Clobazam Tablets Clobazam Suspension Clonazepam Tablets Page 8 of 12
9 Medicines BNF Section 4 Clonazepam Suspension Clonazepam Injection Ethosuximide Capsules Ethosuximide Syrup Gabapentin Capsules Lacosamide Tablets Lacosamide Syrup Lamotrigine Dispersible Tablets Lamotrigine Tablets Lamotrigine Chewable/Dispersible Tablets Levetiracetam Tablets Levetiracetam Oral Solution Levetiracetam Infusion Oxcarbazepine Tablets Oxcarbazepine Suspension Phenobarbital Tablets Phenobarbital Injection Phenobarbital Mixture (Alcohol Free) Phenytoin Suspension Phenytoin Sodium Capsules Phenytoin Sodium Injection Pregabalin Capsules Primidone Tablets Retigabine Tablets Sodium Valproate Crushable Tablets Sodium Valproate E/C Tablets Page 9 of 12
10 Medicines BNF Section 4 Sodium Valproate Sf Liquid Sodium Valproate Injection Sodium Valproate E/C Tablets Sodium Valproate M/R Sachets Sodium Valproate M/R Tablets Topiramate Tablets Topiramate Sprinkle Capsules Vigabatrin Sachets Vigabatrin Tablets Zonisamide Capsules Diazepam Rectal Tubes Diazepam Emulsion Injection Diazepam Injection Paraldehyde Enema 4.9 Drugs used in parkinsonism and related disorders Amantadine Capsules Amantadine Syrup Apomorphine Injection Cabergoline Tablets Co-Beneldopa Capsules Co-Beneldopa Dispersible Tablets Co-Beneldopa M/R Capsules Co-Careldopa M/R Tablets Co-Careldopa Tablets Entacapone Tablets Pergolide Tablets Page 10 of 12
11 Medicines BNF Section 4 Pramipexole Tablets Pramipexole M/R Tablets Rasagiline Tablets Ropinirole Tablets Ropinirole M/R Tablets Rotigotine Patches Selegiline 1. Tablets Selegiline Liquid Stalevo Tablets Orphenadrine Sf Elixir Orphenadrine Tablets Procyclidine Injection Procyclidine Tablets Procyclidine Sf Syrup Trihexyphenidyl Tablets Trihexyphenidyl Syrup Botulinum A Toxin Injection Riluzole Tablets Tetrabenazine Tablets 4.10 Drugs used in substance dependence Acamprosate E/C Tablets Bupropion (Amfebutamone) M/R Tablets Methadone Sf Solution (Green) Nicorette Inhalator Nicorette Patches Nicorette Gum Page 11 of 12
12 Medicines BNF Section 4 Nicorette S/L Tablets Nicorette Nasal Spray Nicorette Gum Nicorette Invisi Patch Nicotinell Lozenges Nicotinell Patches Niquitin Cq Patches Niquitin Cq Lozenges Varenicline Tablets 4.11 Drugs for dementia Donepezil Orodispersible Tablets Donepezil Tablets Galantamine Tablets Galantamine M/R Capsules Galantamine Solution Memantine Tablets Rivastigmine Capsules Rivastigmine Patches Page 12 of 12
Chapter 4 ~ Central nervous system
Chapter 4 ~ Central Nervous System: General Section 1 of 6 Chapter 4 ~ Central nervous system 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics CHLORAL HYDRATE CLOMETHIAZOLE NITRAZEPAM TEMAZEPAM TRICLOFOS
More informationChapter 4 ~ Central nervous system
Chapter 4 ~ Central Nervous System: Special Section 1 of 5 Chapter 4 ~ Central nervous system 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics LOPRAZOLAM Tablet 1mg LORMETAZEPAM Tablet 500microgram PROMETHAZINE
More informationSouth London and the Maudsley NHS Foundation Trust Medicines Formulary
South London and the Maudsley NHS Foundation Trust Medicines Formulary Medicine Formulations Restrictions Additional Information / Related NICE Technology Appraisal 4.1 Hypnotics and anxiolytics 4.1.1
More informationNI Formulary: Chapter 4 Central Nervous system
Hypnotics Anxiolytics Acute state Non drug treatment Temazepam tablets 10mg, 20mg; oral solution 10mg/5ml or Zolpidem tablets 5mg, 10mg or Zopiclone 3.75mg, 7.5mg Non drug treatment Diazepam tablets 2mg,
More informationSafe transfer of prescribing guidance
Safe transfer of prescribing guidance TEWV Prescriber Summary Application required before prescribing Products requiring an application, before prescribing, using the single application form Unlicensed
More informationChapter 4 Central Nervous System
Chapter 4 Central Nervous System 4.1 Hypnotics and anxiolytics. Insomnia Underlying causes should be identified and treated e.g. depression, anxiety, pain, pruritis, and dyspnoea. In-patients who are prescribed
More information4: Central Nervous System
Original Date of issue: 26/11/2005 Last eviewed:10/10/2012 Version:4 Page 1 of 25 4: entral Nervous System 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics Temazepam SF Solution (10mg/5ml) Temazepam Tablets
More informationFormulary Item Restrictions and/or Advice Site availability
Formulary Item Restrictions and/or Advice Site availability C&W CNWL Typical Antipsychotic drugs Chlorpromazine 25mg Chlorpromazine 50mg Chlorpromazine 100mg Chlorpromazine 25mg/5ml syrup Chlorpromazine
More informationALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY
ANTIDEPRESSANTS Serotonin Selective Reuptake Inhibitors citalopram 10, 20, 40 mg, 10 mg/5cc $ 0.40 No escitalopram 10, 20 mg $ 2.60 Yes fluoxetine 10, 20 mg, 20 mg/5 ml $ 0.40 Yes fluvoxamine 25, 50, 100
More informationJoint Formulary for Psychotropic Medication.
Joint for Psychotropic Medication. This document has been produced in collaboration with the Lancashire Commissioning Support Unit Page 1 Table of Contents Section Page Number Page 2 Definition of categories
More informationThis document has been produced in collaboration with the Lancashire Commissioning Support Unit
Joint for Psychotropic Medication. This document has been produced in collaboration with the Lancashire Commissioning Support Unit Date: December 2014. Reviewed August 2016. Next review Date April 2019
More informationDerbyshire Medicines Management, Prescribing and Guidelines DERBYSHIRE PRIMARY CARE FORMULARY
Derbyshire Medicines Management, Prescribing and Guidelines DERBYSHIRE PRIMARY CARE FORMULARY Chapter 4: CENTRAL NERVOUS SYSTEM Updated: March 2017 Drugs and driving From March 2015 a new driving offence
More informationTherapeutic Drugs Monitoring TDM 2018 Therapeutic Drugs Monitoring Scheme Application Form
complete all sections below and return to LGC Standards Proficiency Testing by email, fax or post. Returning customer Lab ID: TM Purchase order no.: (compulsory) TDM Distribution Schedule Samples for the
More informationMedicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay
Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay (Revised edition November 2015) The Medicine Related Falls Risk Assessment
More informationFORMULARY AND PRESCRIBING GUIDELINES 2017
FORMULARY AND PRESCRIBING GUIDELINES 2017 1 Document Control Summary Issue Date Amended Section /page Author/ Amended by 1. Sept 06 All Jane Moriba Summary of Change Removed Trust policy and guideline
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Neuropathic pain pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist
More informationTherapeutic Drugs Monitoring TDM 2016 Therapeutic Drugs Monitoring Scheme Application Form
complete all sections below and return to LGC Standards Proficiency Testing by email, fax or post. Returning customer Lab ID: TM Purchase order no.: (compulsory) TDM Distribution Schedule Samples for the
More informationChapter 4 Central Nervous System
Chapter 4 page number 1 Chapter 4 Central Nervous System First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary
More informationChapter 4 Central Nervous System
Chapter 4 page number 1 Chapter 4 Central Nervous System First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary
More informationCalgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015
Calgary Long Term Care Formulary Pharmacy & Therapeutics February 2015 Highlights http://www.albertahealthservices.ca/4070.aspx 1 Contents February 2016... 3 Added Product(s)... 3 Not Listed, Delisted
More informationNSFT Formulary. Double Red Not recommended for routine use/not commissioned. These drugs have not been recommended for routine use at present.
Traffic Light Status NSFT Formulary Not recommended for routine use/not commissioned. These drugs have not been recommended for routine use at present. Hospital/Specialist only Drugs for which the Trust
More informationtablet/capsule Paracetamol 500mg
Formulary Item Restrictions and/or Advice Non-opioid analgesics + compound analgesic preparations Aspirin 75mg dispersible Aspirin 300mg dispersible Aspirin 300mg Aspirin 75mg EC Paracetamol 500mg / Paracetamol
More informationChapter 4 Central Nervous System
Chapter 4 page number 1 Chapter 4 Central Nervous System First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationPregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)
Pregnancy General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) In all women of child bearing potential Always discuss the possibility of pregnancy; half of all pregnancies are unplanned
More informationDrug Adherence Assessment Report
Prescribed Medications: Drug Adherence Assessment Report FENTANYL, OXYCODONE CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED ANTICIPATED TEST PRESCRIPTION (S)
More informationPrescriber s Guide. Stahl s Essential Psychopharmacology
Stahl s Essential Psychopharmacology Prescriber s Guide FIFTH EDITION With the range of psychotropic drugs expanding and the usages of existing medications diversifying, we are pleased to present this
More informationChapter 4 Central Nervous System Answers. 1. What advice would you provide to someone who has just been initiated on Temazepam for insomnia?
Chapter 4 Central Nervous System Answers 1. What advice would you provide to someone who has just been initiated on Temazepam for insomnia? May impair judgement and increase reaction time, and so affect
More informationMedicine Related Falls Risk Assessment Tool (MRFRAT)
Medicine Related Falls Risk Assessment Tool (MRFRAT) The Medicine Related Falls Risk Assessment tool (MRFRAT) in Appendix 1 is designed to help identify patients at risk of falls due to their current medicine
More informationAPPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline
Drug name APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline Unit costs and weighted average unit costs for drug used in the treatment of focal and generalised epilepsies Prescription Cost
More informationTherapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015
Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A 294.3 for use in Northern Ireland) Sep 2015 BNF 1.3.5 Proton pump inhibitors Lansoprazole orodispersible
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More informationUse of Psychotropic Medications in Older Adults with Dementia!
Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775 About Me Deepa Pattani, PharmD, RPh with
More informationDT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %
June 2016 On 13th May, the DH announced that there would be reductions to Category M prices from June until September. http://psnc.org.uk/our-news/contractor-notice-category-m-price-reduction/ This has
More informationINTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY
INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY A report from the Office of Epidemiology and Planning Baltimore
More informationForensic Toxicology Scope of Testing and Detection Limits
Forensic Toxicology Scope of Testing and Detection Limits Table of Contents QUALITATIVE ANALYSES... 2 Volatile Screen by GC/FID... 2 Carbon Monoxide by Microdiffusion... 2 Ethylene Glycol by GC/MS... 2
More informationINTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY
2009 FINAL REPORT INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY This report was prepared by: Dr. Jose Arbelaez, M.D. of Baltimore Substance Abuse Systems, and Ryan J. Petteway,
More informationPORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5
Abiraterone Tablet 250 mg Q4 2015 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Q4 2014 Alendronic Acid Tablet 70 mg Available Amisulpride Tablet 50 ; 100 ; 200 ; 400 mg Available
More information3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years
Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - MEDICATION DETECTED (PARENT DRUG
More informationWhat s New 2003? What new treatments? What have you discontinued? More information please!
What s New 2003? What new treatments? What have you discontinued? More information please! 1 What s New 2003? Submissions = 137 UK = 52 (38%) Doctors = 60% Nurses = 25% Pharmacists = 15% 2 What s New?
More informationABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR
ABILIFY INJ ABILIFY MAINTENA PREFILLED SYRINGE 300 MG ABILIFY MAINTENA PREFILLED SYRINGE 400 MG ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG Claim will pay automatically for ABILIFY MAINTENA if
More informationWest London Mental Health NHS Trust Formulary
West London Mental Health NHS Trust Formulary VERSION 3.0 (18.02.15) The Formulary is a list of medicines used for mental health indications for patients cared for in all settings of West London Mental
More information3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years
Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: HYDROMORPHONE (DILAUDID, EXALGO), CYCLOBENZAPRINE (FLEXERIL), METHADONE (METHADOSE),
More informationWest London Mental Health NHS Trust Formulary
West London Mental Health NHS Trust Formulary VERSION 7.0 (09.11.16) The Formulary is a list of medicines used for mental health indications for patients cared for in all settings of West London Mental
More informationAlaska Medicaid 90 Day** Generic Prescription Medication List
1 ACYCLOVIR 200 MG CAPSULE BUPROPION HCL 150 MG TAB ER 24H ACYCLOVIR 200 MG/5ML BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 400 MG TABLET BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 800 MG TABLET BUPROPION HCL
More informationPalliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers
Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers This formulary is current as of February 11, 2010. Important Notes: Pharmacists must submit a claim on PharmaNet at the time
More informationSMOKING AND DRUG INTERACTIONS
Medicines Information Centre Pharmacy Department UK Medicines Information SMOKING AND DRUG INTERACTIONS Introduction Smoking rates are significantly higher among people with mental health problems. It
More informationGuide to the Long-Term Illness (LTI) Scheme
Guide to the Long-Term Illness (LTI) Scheme 1 Contents What is the Long-Term Illness (LTI) scheme? What are the diseases and disabilities covered by the LTI scheme? How do I find out if I am entitled to
More informationNICE Approved & locally requested & authorised through the Drug & Therapeutics Committee
Formulary NICE Approved & locally requested & authorised through the Drug & Therapeutics Committee BNF Code Drug Description 01.01.01 ANTACID AND OXETACAINE SF SUSPENSION (150mL) SIMETICONE 40mg/mL SF
More informationWhile there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.
April 2018 The usual quarterly of Category M prices Another set of similar comments as I made in January: significant increases in many lines which have been subject to price concessions but even more
More informationNervous System. Chapter 4 TABLE OF CONTENTS
Chapter 4 Nervous System 2.1 Hypnotics & anxiolytics... 7 2.1.1 Hypnotics... 7 2.1.2 Anxiolytics... 7 2.2 Dependence and Withdrawal... 7 TABLE OF CONTENTS Table of Contents... 1 1 Epilepsy and other seizure
More informationKern Pharma Portfolio 2014
Kern Pharma Portfolio 2014 DOSSIERS DEVELOPED DURING 2013-2014 ARIPIPRAZOL (ODT) 10mg, 15mg tablets CHONDROITIN SULPHATE 400mg capsules ( well established use ) DEXKETOPROFEN TROMETAMOL 25mg, tablets DULOXETIN
More informationOhana Community Care Services (CCS) Comprehensive Preferred Drug List (List of Covered Drugs)
2015 Ohana Community Care Services (CCS) Comprehensive referred Drug List (List of Covered Drugs) Ohana Health lan 00 lease read: This document contains information about the drugs we cover in this plan.
More informationIndex. Index. More information
acamprosate, alcohol dependence, 223 225, 227 228, 252 acetylcholine, role in Alzheimer s disease, 263 aerobic exercise, panic disorder, 81 agitation, schizophrenia sedation strategies, 21 agomelatine,
More informationPORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6
Abiraterone Tablet 250 mg Q4 2016 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Available Alendronic Acid Tablet 70 mg Available Amikacin Solution for injection 50 mg/ml; 125mg/ml;
More informationIMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
More informationPSYCHIATRY DRUG ALERTS, VOLUME XXVIII, 2014 INDEX
A acamprosate ADHD Generic Methylphenidate Equivalence, 84 Methylphenidate in Pregnancy, 9 Stimulants in Pregnancy, 50 adverse effects Antidepressant-Induced Jitteriness, 94 Antidepressants and Sexual
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationBACKGROUND Measuring renal function :
A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal
More informationDrugs Found in Medical Examiner Cases
s Found in Medical Examiner Cases 1,1 difluoroethane propellant in aerosols 10-Hydroxycarbazepine 11-Hydroxy Delta-9 THC 6-monoacetylmorphine 7-amino clonazepam acetaminophen acetone alpha-hydroxyalprazolam
More informationTN Cover Rx Tennessee CoverRx MAC Price Change List As of: 04/26/2018
1 Tennessee CoverRx List Run : 04/26/18 Dosage Form amiodarone HCl 200 MG TABLET ORAL 04/25/2018 0.16102 0.14405 11.8 hydralazine HCl 100 MG TABLET ORAL 04/25/2015 0.11390 0.10854 4.9 hydralazine HCl 25
More informationAAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
AAA Adolescents & Adults with Autism A Study of Family Caregiving add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
More informationRetrospective Drug Use Review for the Use of Psychotropic Medications in Children
Retrospective Drug Use Review for the Use of Psychotropic Medications in Children Recommendations Send providers an annual request for additional clinical data for children receiving any of the following
More informationU T I L I Z A T I O N E D I T S
I N D I A N A H E A L T H C O V E R A G E P R O G R A M S U T I L I Z A T I O N E D I T S A P R I L 1 9, 2 0 1 2 s for s Refer to Provider Bulletin BT200709 for additional information regarding the Mental
More informationIndex. baclofen 73 basal forebrain nuclei 174
Index acetazolamide 33 acetylcholine esterase inhibitor 174 actigraphy 14 activity meter 226 acute insomnia 4 α1 adrenergic activity 88 α 1 containing receptor 211 adenosine 108 advanced sleep phase syndrome
More informationNorthSTAR. Pharmacy Manual
NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics
More informationFORMULARY AND PRESCRIBING GUIDANCE
FORMULARY AND PRESCRIBING GUIDANCE GUIDELINE VERSION 18 RATIFYING GROUP Drugs and Therapeutics Group (DTG) DATE PUBLISHED NEXT REVIEW DATE (see specific guidelines) FORMULARY SPONSOR Executive Medical
More informationDT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M %
December 16 No Category M changes so the reductions imposed in May which were only supposed to last until September continue As in November, most changes are Category A lines with a few Category C. Significant
More informationTennCare Program TN MAC Price Change List As of: 03/30/2017
1 TN List Run : 03/30/17 Old PRAZOSIN HCL 5 MG CAPSULE ORAL 03/29/2017 1.11209 1.12560 ( 1.2) CAPTOPRIL 12.5 MG TABLET ORAL 07/07/2015 1.07191 1.10416 ( 2.9) ISOSORBIDE DINITRATE 5 MG TABLET ORAL 03/29/2017
More information3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.
Drug Adherence Assessment Report Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED PRESCRIPTION FLAG ANTICIPATED
More informationImpact of Frailty in HF
Impact of Frailty in HF Biykem Bozkurt, MD, FACC The Mary and Gordon Cain Chair & Professor of Medicine Medical Care Line Executive, DeBakey VA Medical Center, Director, Winters Center for HF Research,
More informationSYRINGE DRIVER MEDICATIONS
SYRINGE DRIVER MEDICATIONS Christine Hull & Anita Webb Staff Nurses, Hospice in the Home 2015 Analgesics:- Groups of Medication used in Syringe Drivers Morphine sulphate Diamorphine Oxycodone Alfentanil
More informationProfessor David Castle. Ms. Nga Tran. St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065
ARABIIC Professor David Castle Ms. Nga Tran St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065 (03) 9288 4147 (03) 9288 4751 Psychiatric Medication Information / Arabic 1 Psychiatric
More informationT2/T3/S62/CT012 Aide Memoire
Correct way to fill out MHA forms T2/T3/S62/CTO12 SH CP 224 T2/T3/S62/CT012 Aide Memoire Version: 2 Summary: An Aide Memoire to completing or requesting a T2/T3/S62/CT012 Keywords: Target Audience: T2,
More informationDoncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary
Doncaster & Bassetlaw Cancer Locality Palliative Core Formulary Approved by Doncaster & Bassetlaw Hospitals NHS Foundation Trust Drugs and Therapeutics Committee. DJ14/2155 Oct 2014 Review date: Oct 2017
More informationNATIONAL PRESCRIBING INDICATORS DRUG BASKETS
NATIONAL PRESCRIBING INDICATORS 2014 2015 DRUG BASKETS INTRODUCTION The National Prescribing Indicators (NPIs) 2014 2015 were developed by the All Wales Prescribing Advisory Group (AWPAG), and underwent
More informationIndex. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
More informationDT Description Price Category Price change Percentage
June 2017 A slight inflationary pressure in most CCGs from mainly Category A increases. Significant price increases: Most of low concern although those involving the less frequently used tamoxifen strengths
More informationStep Therapy Medications
Step Therapy Medications Step Therapy Group APTIOM Step-2: APTIOM 200 MG TABLET or APTIOM 400 MG TABLET or APTIOM 600 MG TABLET or APTIOM 800 MG TABLET Step 1 Drug(s): Oxcarbazepine immediate-release,
More informationAlprazolam 0.25mg, 0.5mg, 1mg tablets
Presbyterian Senior Care (HMO) / Presbyterian MediCare PPO Quantity Limits Effective November 1, 2014 For the most recent list of drugs or other questions, please contact the Presbyterian Customer Service
More informationPRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist
PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines
More informationDrugs used for the treatment of depression Selective Serotonin Reuptake Inhibitors Tricyclic and related antidepressants Others antidepressants
Central Nervous System Drugs used for the treatment of depression Anxiolytics and hypnotics Drugs used in psychosis and related disorders Drugs used in substance dependence for patients with established
More informationFormulary. BlueMedicare SM Comprehensive. BlueMedicare Value (PPO) H ,024,025
BlueMedicare SM Comprehensive Formulary BlueMedicare Value (PPO) H5434-023,024,025 This formulary was updated on 12/28/2018. For more recent information or other questions, please contact Florida Blue
More informationMedication For Migraine Chart: Table 1: Acute Treatment when the attack begins
Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins Page a Analgesics (painkillers) Non-steroidal antiinflammatory drugs (NSAIDs) Prescription required Brand Name Formulation
More information2015 Annual Physician Notice
0 Annual Physician Notice The Office of Inspector General (OIG) recommends clinical laboratories send notices to physicians and other providers who use their services, at least once a year, to inform the
More informationPARKINSON S MEDICATION
PARKINSON S MEDICATION History 1940 50 s Neurosurgeons operated on basal ganglia. Improved symptoms. 12% mortality 1960 s: Researchers identified low levels of dopamine caused Parkinson s leading to development
More informationPROGRAM General Information
Association for Quality Assessment in TDM and Clinical Toxicology Section of the Dutch Foundation for Quality Assessment in Medical Laboratories PROGRAM 2016 General Information P.O. Box 43100, 2504 AC
More informationAppendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
More informationTreating sleep disorders
Treating sleep disorders Sue Wilson Centre for Neuropsychopharmacology Imperial College London sue.wilson@imperial.ac.uk Suggested algorithm for treatment of insomnia Diagnosis of insomnia Associated with
More informationAny interventions, where RCTs in PD are not available, are not included in the tables.
Tables Interventions where new studies have been published are indicated in bold italics. Changes in conclusions are indicated in italics and are highlighted in yellow. Any interventions, where RCTs in
More informationConservative Management of Uraemia
Conservative Management of Uraemia Information for Health Professionals Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact: The Renal Specialist
More information2017 Formulary (List of Covered Drugs)
Enhanced 2017 Formulary (List of Covered Drugs) HPMS Approved Formulary File Submission ID 17121, Version Number 15 This document contains information about the drugs we cover in this plan. For more recent
More informationVolume 4; Number 17 November 2010
Volume 4; Number 17 November 2010 USE OF UNLICENSED PHARMACEUTICAL SPECIALS What are pharmaceutical specials? A pharmaceutical special as defined by law is a medicine made to satisfy an individual patient
More informationSYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL
SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation
More informationBramley Health Formulary March 2016 Review Date March 2017
Bramley Health Formulary March 2016 Review Date March 2017 This provides a formulary for use within Bramley Health. This only relates to psychiatric indications. Some of the medicines listed are also used
More informationAnalgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-
Page 1 of 8 Analgesia The World Health Organisation (WHO, 1990) has devised a model to assist health care professionals in the management of cancer pain. The recommendations include managing pain, by the
More informationGuide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
More information